ロード中...
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
BACKGROUND: Malignant mesothelioma (MM) is an aggressive tumor that is resistant to conventional modes of treatment with chemotherapy, surgery or radiation. Research into the molecular pathways involved in the development of MM should yield information that will guide therapeutic decisions. Epiderma...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2828989/ https://ncbi.nlm.nih.gov/pubmed/20122271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-27 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|